More Research

Avacta

AVA6000 set to start US Phase I studies in early-2022
Lighthouse | 29 Nov 2021

Avacta

Foundations for two healthy businesses now in place
Lighthouse | 30 Sep 2021

Avacta

Lead therapeutic asset AVA6000 enters the clinic
Lighthouse | 11 Aug 2021

Avacta

So much more than a play on COVID testing
Initiation | 29 Jun 2021

Return to Avacta
© 2019-21 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).